M281 clinical trials

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

This study is looking into a new medication, M281, for adults with a blood condition called warm autoimmune hemolytic anemia (wAIHA). It aims to see if the medicine is effective and safe compared to a dummy treatment. Participants will be treated for a long time, with close monitoring.